Please login to the form below

Not currently logged in
Email:
Password:

ASBM

This page shows the latest ASBM news and features for those working in and with pharma, biotech and healthcare.

Novartis weighs in on biosimilar naming debate

Novartis weighs in on biosimilar naming debate

However, this process has been challenged in recent months by groups, such as the Alliance for Safe Biologic Medicines (ASBM), who argue that biosimilar medicines should have their own distinct scientific ... The ASBM, whose members include biologic drug

Latest news

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...

Infographics